(PharmaNewsWire.Com, February 14, 2019 ) EU5 Conjugate Vaccine Market:Conjugate Vaccine is a type of vaccine that contains bacterial capsular polysaccharide, attached to a protein to enhance immunogenicity and protect against invasive diseases. EU5 is one of the most prominent markets for conjugate vaccines. The U.K. was the first country to introduce MenB-4C into their National Infant Immunization Program (2015). In all EU/EEA countries, Hib vaccination has been part of the immunization programs, since 2010, and high coverage has been sustained.
o Based on disease indication, the market is segmented into pneumococcal, haemophilus influenza type b, diphtheria-tetanus-pertussis, meningococcal and others. The highest penetration among paediatrics is that of the DTP vaccine. o Based on end user, the market is segmented into pediatric and adult.
Key growth factors:
The EU5 is projected to have positive growth during the forecasted period. A higher number of vaccination programs by the governments, increase in geriatric population, government initiatives and increase in research and development activities together propel the growth of this market. Germany will grow at a considerable rate over the coming years owing to increasing government initiatives which offer medical advice for the vaccination of children. Rising prevalence of infectious diseases and focused product development will fuel industry expansion.
Threats and key players:
o The EU5 Conjugate Vaccine Market is expected to grow at a constant pace. Vaccine shortages, low access and stringent regulations are some of the challenges faced by this market which need to be addressed to achieve smooth growth. o Major conjugate vaccine providers operating in the market are GlaxoSmithKline, Pfizer Inc., Merck, Novartis, Sanofi Pasteur, etc.
Chapter 1: Executive summary 1.1 Market scope and segmentation 1.2 Key questions answered in this study 1.3 Executive summary - I 1.4 Executive summary - II
Chapter 3: EU5 major segment overview - by disease indication 3.1. Disease indication: Pneumococcal, Hib - by revenue, by volume, CAGR - Overview - by disease indication - Market share (2015, 2018 & 2023): Pneumococcal – EU5 (USD Bn, Million units) - Market share (2015, 2018 & 2023): Hib – EU5 (USD Bn, Million units) 3.2. Disease indication: DTP, Meningococcal - by revenue, by volume, CAGR - Overview - by disease indication - Market share (2015, 2018 & 2023): DTP – EU5 (USD Bn, Million units) - Market share (2015, 2018 & 2023): Meningococcal – EU5 (USD Bn, Million units)
Chapter 4: EU5 major segment overview - by end user 4.1. End user: Pediatric, Adult - by revenue, by volume, CAGR - Overview - by end user - Market share (2015, 2018 & 2023): Paediatric – EU5 (USD Bn, Million units) - Market share (2015, 2018 & 2023): Adult – EU5 (USD Bn, Million units)
Chapter 5: Competitive landscape 5.1. Company market share - Top 5 companies 5.2. Company overview - GlaxoSmithKline - Company snapshot - Product offerings - Growth strategies - Initiatives - Geographical presence 5.2(A) Executive profile – GlaxoSmithKline 5.3. Company overview – Pfizer Inc. - Company snapshot - Product offerings - Growth strategies - Initiatives - Geographical presence 5.3(A) Executive profile - Pfizer Inc. 5.4. Company overview – Merck & Co. - Company snapshot - Product offerings - Growth strategies - Initiatives - Geographical presence 5.4(A) Executive profile - Merck & Co. 5.5. Company overview – Novartis - Company snapshot - Product offerings - Growth strategies - Initiatives - Geographical presence
Research Report Hub Research Report Hub offers wide-ranging collection of market research reports under virtually every market verticals and sub-categories from different publishers across the globe. We offer reliable market intelligence reports and report customization services to better understand current and projected market scenarios. It also gives a clearer depiction of industries and facilitates to simply perceive competitor activity in the respective industry. Our services are also geared towards helping organizations procure market reports at the finest price. About US
Research Report Hub Sector 04, Plot 101, Sant Nagar, Moshi PCNDTA, Pune, 412105 Maharashtra, India
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
